Innate Pharma
IPHA
#9114
Rank
โ‚ฌ0.14 B
Marketcap
1,55ย โ‚ฌ
Share price
0.57%
Change (1 day)
-2.78%
Change (1 year)

Revenue for Innate Pharma (IPHA)

Revenue in 2025: โ‚ฌ2.78 Million

According to Innate Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.86 Million. In 2025 the company made a revenue of โ‚ฌ2.78 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ12.62 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innate Pharma from 2005 to 2025

Annual revenue

Year Revenue Change
2025โ‚ฌ2.78 M-77.92%
2024โ‚ฌ12.62 M-75.68%
2023โ‚ฌ51.9 M4.68%
2022โ‚ฌ49.58 M309.41%
2021โ‚ฌ12.11 M-78.43%
2020โ‚ฌ56.15 M-18.15%
2019โ‚ฌ68.6 M-14.12%
2018โ‚ฌ79.89 M144.83%
2017โ‚ฌ32.63 M-41.9%
2016โ‚ฌ56.16 M213.64%
2015โ‚ฌ17.9 M1874.2%
2014โ‚ฌ0.9 M-92.73%
2013โ‚ฌ12.46 M20.16%
2012โ‚ฌ10.37 M39.21%
2011โ‚ฌ7.45 M72.55%
2010โ‚ฌ4.32 M-44.01%
2009โ‚ฌ7.71 M-40.3%
2008โ‚ฌ12.92 M-9.56%
2007โ‚ฌ14.29 M68.57%
2006โ‚ฌ8.47 M246.85%
2005โ‚ฌ2.44 M